KLK3 and posterior cortical atrophy: Our subgroup analysis of a cohort from the population‐based Swiss arm of the ERSPC evaluated the effect of statins on PSA values and the overall relative risk of PCa in patients systematically screened for PCa and followed for a median of 9.6 years [10].